Company news
Neuroscientific Biopharmaceuticals Ltd. news in 2026
Neuroscientific Biopharmaceuticals Ltd.'s news releases, calls and decks from 2026, newest first.
Quarterly Activities/Appendix 4C Cash Flow Report
October 26, 2026
Leading CRO Appointed for Phase 2 Crohn's Trial
September 30, 2026
2026 Annual Report & Appendix 4E
August 25, 2026
Remarkable Results from Patients treated with StemSmart
May 25, 2026
Half Yearly Report and Accounts
February 25, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 29, 2026
Successful Clinical Results Achieved under Special Access
January 12, 2026
Trading Halt
January 8, 2026
Decks in 2026
- ISCT ANZ 2026
Conference · 12 slides · Jul 21, 2026
- Investor Presentation (May 2026)
Investor deck · 16 slides · May 26, 2026
- JMM Investor Lunch February 2026
Conference · 15 slides · Feb 16, 2026